MarketWatch: Pfizer beat earnings but here’s why this analyst downgraded the stock to neutral 5 de maio de 2021 by r4ibom in Uncategorized Mizuho Securities says the pharma giant needs its pipeline to deliver for investors to gain more comfort with Pfizer’s outlook. Compartilhe isso: Clique para compartilhar no X(abre em nova janela) 18+ Clique para compartilhar no Facebook(abre em nova janela) Facebook 5 de maio de 2021
